Abstract：Objective To investigate the effect of Neixiao Luoli Pills combined with western medicine in the treatment of cavitary nontuberculous mycobacterium (NTM) lung disease,and to provide a new therapeutic idea for clinical treatment.Methods Sixty-three patients with cavitary NTM lung disease admitted to Chest Hospital of Jiangxi Province from July 2020 to April 2023 were retrospectively analyzed,and divided into western medicine group (35 cases) and combined group (28 cases) according to treatment regimen.The western medicine group was treated with basic treatment,and the combined group was treated with Neixiao Luoli Pills.The main clinical manifestations and the changes of lesion extent and cavity in chest CT signs were observed in the two groups after intervention for 3 months.Results The treatment effect of cough and hemoptysis in combination group was better than that in western medicine group,and the total effective rate was higher than that in Western medicine group,the difference was statistically significant (P＜0.05).There was no significant difference in the treatment effect and total effective rate of chest tightness between the two groups (P＞0.05).Among the chest CT signs,the absorption of lung lesions and closure of cavity lesions in the combined group were better than those in the western medicine group,and the differences were statistically significant (P＜0.05).Conclusion Neixiao Luoli Pills combined with western medicine in the treatment of NTM lung disease can accelerate the remission of clinical symptoms and shorten the course of disease.The results of chest CT provide data support for the curative effect,which is worthy of clinical promotion and application.
黄河1； 谢伟2； 曾云龙3. 内消瘰疬丸联合西药治疗空洞型非结核分枝杆菌肺病的效果观察[J]. 中国当代医药, 2024, 31(13): 67-70.
HUANG He1 XIE Wei2 ZENG Yunlong3. Observation on the effect of Neixiao Luoli Pills combined with Western medicine in the treatment of cavitary nontuberculous mycobacteria lung disease. 中国当代医药, 2024, 31(13): 67-70.
Winthrop KL，Marras TK，Adjemian J，et al.Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S.Managed Care Health Plan，2008-2015[J].Ann Am Thorac Soc，2020，17（2）：178-185.
[2]
Tzou CL，Dirac MA，Becker AL，et al.Association between Mycobacterium avium Complex Pulmonary Disease and Mycobacteria in Home Water and Soil [J].Ann Am Thorac Soc，2020，17（1）：57-62.
[3]
Lee MR，Chang LY，Ko JC，et al.Nontuberculous mycobacteriallungdiseaseepidemiologyinTaiwan：Asystematicreview[J].J Formos Med Assoc，2020，119（Suppl 1）：S4-S12.
[4]
Sharma SK，Upadhyay V.Non-tuberculous mycobacteria：a disease beyond TB and preparedness in India[J].Expert Rev Respir Med，2021，15（7）：949-958.
[5]
Boonjetsadaruhk W，Kaewprasert O，Nithichanon A，et al.High rate of reinfection and possible transmission of Mycobacterium avium complex in Northeast Thailand[J].One Health，2022，14：100374.
[6]
任坦坦，陆普选，邓国防，等.2020 WHO 全球结核报告：全球与中国关键数据分析[J].新发传染病电子杂志，2020，5（4）：280-284.
京公网安备 11010502046607号